HSA — authorised 5 February 2014
- Marketing authorisation holder: SANDOZ
- Status: likely_approved
🇸🇬 Cefpodoxime Proxetil in Singapore
HSA authorised Cefpodoxime Proxetil on 5 February 2014
Marketing authorisations
HSA
- Marketing authorisation holder: AUROBINDO PHARMA
- Status: likely_approved
Cefpodoxime Proxetil in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Singapore
Frequently asked questions
Is Cefpodoxime Proxetil approved in Singapore?
Yes. HSA authorised it on 5 February 2014; HSA has authorised it.
Who is the marketing authorisation holder for Cefpodoxime Proxetil in Singapore?
SANDOZ holds the Singaporean marketing authorisation.